With Fevertree still priced at growth stock valuations, it pays to be cautious.
Brown-Forman Corp. Cl A 1.22% $14.62B Brown-Forman Corp. Cl B 1.07% $14.62B Carlsberg A/S Series B 0.05% kr.108.67B Carlsberg A/S Series A-0.88% kr.108.67B ...
StockNews.com lowered shares of Molson Coors Beverage (NYSE:TAP – Free Report) from a buy rating to a hold rating in a ...
Citigroup upgraded shares of Molson Coors Beverage (NYSE:TAP – Free Report) from a sell rating to a neutral rating in a research note released on Wednesday, Marketbeat.com reports. They currently have ...
Evercore ISI lowered the firm’s price target on Molson Coors (TAP) to $60 from $68 and keeps an Outperform rating on the shares ahead of the company’s Q4 report due on Thursday, February 13.
Citi upgraded Molson Coors (TAP) to Neutral from Sell with a price target of $57, up from $47. The firm says its fundamental thesis has largely played out, with Molson share trends moving to down ...
CHICAGO, January 30, 2025--(BUSINESS WIRE)--Molson Coors Beverage Company ("Molson Coors" or "the company") (NYSE: TAP, TAP.A) is expanding its U.S. non-alc portfolio through a new strategic ...
Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of $74.00. Christopher Carey’s rating is based on Molson ...
Also, Molson Coors has acquired an 8.5% ownership stake in Fever-Tree, positioning itself as the second-largest shareholder in the mixer brand. The financial terms were not disclosed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results